(64)Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients

BACKGROUND: The purpose of this study was to determine whether brain metastases from HER2-positive breast cancer could be detected noninvasively using positron emission tomography (PET) with (64)Cu-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-trastuzumab. METHODS: PET was performe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurihara, Hiroaki, Hamada, Akinobu, Yoshida, Masayuki, Shimma, Schuichi, Hashimoto, Jun, Yonemori, Kan, Tani, Hitomi, Miyakita, Yasuji, Kanayama, Yousuke, Wada, Yasuhiro, Kodaira, Makoto, Yunokawa, Mayu, Yamamoto, Harukaze, Shimizu, Chikako, Takahashi, Kazuhiro, Watanabe, Yasuyoshi, Fujiwara, Yasuhiro, Tamura, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385241/
https://www.ncbi.nlm.nih.gov/pubmed/25853014
http://dx.doi.org/10.1186/s13550-015-0082-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385241/
https://www.ncbi.nlm.nih.gov/pubmed/25853014
http://dx.doi.org/10.1186/s13550-015-0082-6

Ejemplares similares